DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Younis FM, Leor J, Abassi Z. et al
Beneficial effect of the SGLT-2 inhibitor empagliflozin on glucose homeostasis and cardiovascular parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) rat.
J Cardiovasc Pharmacol Ther 2018;
23: 358-371 . doi:10.1177/1074248418763808
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.